A retrospective, population-based matched cohort study was conducted to assess the impact of bariatric surgery on mortality among patients with type 2 diabetes and severe obesity.
Researchers investigate cataract development by examining the anterior lens capsules of patients with and without diabetes.
Treatment with canagliflozin may not significantly lower risk for myocardial infarction among patients with type 2 diabetes and comorbid chronic kidney disease or among patients with diabetes who have a history of or have a high risk for CVD.
A team of researchers sought to assess the effects of dapagliflozin on short-term blood pressure variability indices through 24-hour ambulatory blood pressure monitoring in people with type 2 diabetes.
The prevalence of hypertension and albuminuria in pediatric patients with type 2 diabetes varies by race.
Investigators sought to determine whether age at onset of diabetes is associated with incident dementia.
A study shows periodic dosing can affect the development of proliferative diabetic retinopathy and diabetic macular edema.
The link between long-term blood pressure variability and cardiovascular outcomes were studied in individuals with type 2 diabetes.
The approval was based on data from the DAPA-CKD trial, which compared dapagliflozin, an SGLT2 inhibitor, to placebo on renal outcomes and cardiovascular mortality in patients with CKD.
Researchers conducted a systematic review and meta-analysis about the association of insomnia disorder characterized by objective sleep duration with hypertension, diabetes, and body mass index.